Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis

AIM: To conduct a systematic review and meta‐analysis to understand the timing and factors associated with anti‐programmed cell death protein‐1 (PD‐1)/anti‐programmed cell death protein‐1 ligand (PD‐L1) inhibitor‐induced Type 1 diabetes. METHODS: We searched MEDLINE, EMBASE, SCOPUS and Cochrane data...

Descripción completa

Detalles Bibliográficos
Autores principales: Akturk, H. K., Kahramangil, D., Sarwal, A., Hoffecker, L., Murad, M. H., Michels, A. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Systematic Review or Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698212/
https://www.ncbi.nlm.nih.gov/pubmed/31199005
http://dx.doi.org/10.1111/dme.14050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698212/
https://www.ncbi.nlm.nih.gov/pubmed/31199005
http://dx.doi.org/10.1111/dme.14050

Ejemplares similares